High-Performance Allosteric Conditional Guide RNAs for Mammalian Cell-Selective Regulation of CRISPR/Cas
- Creators
- Hochrein, Lisa M.
- Li, Heyun
- Pierce, Niles A.
Abstract
The activity of a conditional guide RNA (cgRNA) is dependent on the presence or absence of an RNA trigger, enabling cell-selective regulation of CRISPR/Cas function. cgRNAs are programmable at two levels, with the target-binding sequence controlling the target of Cas activity (edit, silence, or induce a gene of choice) and the trigger-binding sequence controlling the scope of Cas activity (subset of cells expressing the trigger RNA). Allosteric cgRNA mechanisms enable independent design of the target and trigger sequences, providing the flexibility to select the regulatory target and scope independently. Building on prior advances in dynamic RNA nanotechnology that demonstrated the cgRNA concept, here we set the goal of engineering high-performance allosteric cgRNA mechanisms for the mammalian setting, pursuing both ON → OFF logic (conditional inactivation by an RNA trigger) and OFF → ON logic (conditional activation by an RNA trigger). For each mechanism, libraries of orthogonal cgRNA/trigger pairs were designed using NUPACK. In HEK 293T cells expressing cgRNAs, triggers, and inducing dCas9: (1) a library of four ON → OFF "terminator switch" cgRNAs exhibit a median fold-change of ≈50×, a median fractional dynamic range of ≈20%, and a median crosstalk modulus of ≈9%; (2) a library of three OFF → ON "split-terminator switch" cgRNAs exhibit a median fold-change of ≈150×, a median fractional dynamic range of ≈50%, and a median crosstalk modulus of ≈4%. Further, we demonstrate that xrRNA elements that protect viral RNAs from degradation by exoribonucleases can dramatically enhance the performance of RNA synthetic biology. The high-performance allosteric cgRNAs demonstrated here for ON → OFF and OFF → ON logic in mammalian cells provide a foundation for pursuing applications of programmable cell-selective regulation.
Additional Information
© 2021 American Chemical Society. Received: January 26, 2021; Published: April 30, 2021. We thank Z. Chen, M. H. Hanewich-Hollatz, J. Huang, and P. W. K. Rothemund for helpful discussions. This work was funded by the Defense Advanced Research Projects Agency (HR0011-17-2-0008; the findings are those of the authors and should not be interpreted as representing the official views or policies of the U.S. Government), by the National Aeronautics and Space Administration (7000000323), by the Rosen Bioengineering Center at Caltech, by the Beckman Institute at Caltech (Programmable Molecular Technology Center, PMTC), and by a Beckman-Gray Graduate Fellowship. The authors declare the following competing financial interest(s): Patent applications filed by the California Institute of Technology.Attached Files
Supplemental Material - sb1c00037_si_001.pdf
Files
Name | Size | Download all |
---|---|---|
md5:d3da0c910c8929add93e34f457baeb31
|
8.3 MB | Preview Download |
Additional details
- Eprint ID
- 108927
- Resolver ID
- CaltechAUTHORS:20210503-115702708
- Defense Advanced Research Projects Agency (DARPA)
- HR0011-17-2-0008
- NASA
- 7000000323
- Donna and Benjamin M. Rosen Bioengineering Center
- Caltech Beckman Institute
- Created
-
2021-05-07Created from EPrint's datestamp field
- Updated
-
2021-05-26Created from EPrint's last_modified field
- Caltech groups
- Rosen Bioengineering Center, Division of Biology and Biological Engineering